The Role of Statin Therapy in Hemorrhagic Stroke

Area of Science:

• Cardiovascular Medicine
• Neurology
• Pharmacology

Background:

• Statins are primary agents for cholesterol reduction and cardiovascular risk management.
• Previous studies suggested statins may increase hemorrhagic stroke risk, but findings are conflicting.
• Recent research indicates potential benefits of statin use around intracerebral hemorrhage (ICH) events.

Purpose of the Study:

• To review current literature on statin therapy in relation to hemorrhagic stroke.
• To evaluate the impact of statin use and discontinuation on patient outcomes after intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage (aSAH).
• To provide guidance for clinical decision-making regarding statin therapy in hemorrhagic stroke patients.

Main Methods:

• Review of existing literature and post hoc analyses.
• Examination of observational studies and clinical trial data.
• Synthesis of evidence regarding statin use prior to, during, and after hemorrhagic stroke events.

Main Results:

• Conflicting data exists on statins and hemorrhagic stroke risk.
• Continuing statins during ICH admission may be associated with better outcomes.
• Abrupt statin discontinuation upon hospital admission may lead to adverse effects.
• Statins initiated during aSAH admission show no additional benefit for delayed ischemic neurologic deficits.

Conclusions:

• The role of statins in hemorrhagic stroke requires further large-scale investigation.
• Clinical decisions on statin therapy should consider the specific type of hemorrhagic stroke and timing of statin initiation or continuation.
• Evidence suggests potential harm from statin withdrawal in critically ill patients.